S&P 500   3,852.36
DOW   32,920.46
QQQ   296.26
Is Buying an Aged Corporation a Good Idea?
Is This The End of Capitalism? (Ad)
MarketBeat Week in Review – 1/23- 1/27
Lots of sound and fury on US debt, but not a crisis — yet
The Next Big Crisis Is Here (Ad)
Italy's premier visits Libya for talks on energy, migration
Japan firm opens whale meat vending machines to push sales
The Next Big Crisis Is Here (Ad)
Italy, Libya sign $8B gas deal as PM Meloni visits Tripoli
Online system to seek asylum in US is quickly overwhelmed
S&P 500   3,852.36
DOW   32,920.46
QQQ   296.26
Is Buying an Aged Corporation a Good Idea?
Is This The End of Capitalism? (Ad)
MarketBeat Week in Review – 1/23- 1/27
Lots of sound and fury on US debt, but not a crisis — yet
The Next Big Crisis Is Here (Ad)
Italy's premier visits Libya for talks on energy, migration
Japan firm opens whale meat vending machines to push sales
The Next Big Crisis Is Here (Ad)
Italy, Libya sign $8B gas deal as PM Meloni visits Tripoli
Online system to seek asylum in US is quickly overwhelmed
S&P 500   3,852.36
DOW   32,920.46
QQQ   296.26
Is Buying an Aged Corporation a Good Idea?
Is This The End of Capitalism? (Ad)
MarketBeat Week in Review – 1/23- 1/27
Lots of sound and fury on US debt, but not a crisis — yet
The Next Big Crisis Is Here (Ad)
Italy's premier visits Libya for talks on energy, migration
Japan firm opens whale meat vending machines to push sales
The Next Big Crisis Is Here (Ad)
Italy, Libya sign $8B gas deal as PM Meloni visits Tripoli
Online system to seek asylum in US is quickly overwhelmed
S&P 500   3,852.36
DOW   32,920.46
QQQ   296.26
Is Buying an Aged Corporation a Good Idea?
Is This The End of Capitalism? (Ad)
MarketBeat Week in Review – 1/23- 1/27
Lots of sound and fury on US debt, but not a crisis — yet
The Next Big Crisis Is Here (Ad)
Italy's premier visits Libya for talks on energy, migration
Japan firm opens whale meat vending machines to push sales
The Next Big Crisis Is Here (Ad)
Italy, Libya sign $8B gas deal as PM Meloni visits Tripoli
Online system to seek asylum in US is quickly overwhelmed
NYSE:ALC

Alcon - ALC Stock Forecast, Price & News

$74.80
-0.13 (-0.17%)
(As of 01/27/2023 12:00 AM ET)
Add
Compare
Today's Range
$73.65
$75.00
50-Day Range
$65.94
$75.72
52-Week Range
$55.21
$81.97
Volume
570,409 shs
Average Volume
681,024 shs
Market Capitalization
$36.66 billion
P/E Ratio
65.04
Dividend Yield
N/A
Price Target
$80.63

Alcon MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.50 Rating Score
Upside/​Downside
7.8% Upside
$80.63 Price Target
Short Interest
Bearish
1.18% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.17mentions of Alcon in the last 14 days
Based on 4 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
12.05%
From $2.24 to $2.51 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.82 out of 5 stars

Medical Sector

833rd out of 1,055 stocks

Ophthalmic Goods Industry

5th out of 7 stocks


ALC stock logo

About Alcon (NYSE:ALC) Stock

Alcon Inc., an eye care company, researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients worldwide. The company's Surgical segment offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for use in surgical procedures. Its cataract products include centurion vision system, LenSx femtosecond laser, LuxOR surgical ophthalmic microscope, NGENUITY 3D visualization system, and ORA system for intra-operative measurements; custom pak surgical procedure packs; vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, and grieshaber and MIVS instruments, as well as scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit vitrectomy probes; refractive surgery products, including WaveLight lasers and Contoura Vision used for LASIK treatment; EX-PRESS glaucoma filtration device; and implantables products, including AcrySof IQ IOLs products include monofocal IOLs and advanced technology IOLs under the PanOptix and ReSTOR brands for the correction of presbyopia and astigmatism at the time of cataract surgery. Its Vision Care segment provides daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, glaucoma, contact lens care, and ocular allergies; and ocular vitamins and redness relievers under the TOTAL, PRECISION, DAILIES AquaComfort PLUS, Air Optix, Opti-Free, Clear Care, Tears Naturale, Genteal, ICAPS, and Vitalux brands. The company was formerly known as Alcon Universal S.A. and changed the name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.

Receive ALC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Alcon and its competitors with MarketBeat's FREE daily newsletter.

ALC Stock News Headlines

The Next Big Crisis Is Here
You just can’t see it yet because it’s NOT a banking, financial, or economic crisis… it’s far worse and threatens every dollar in your retirement account.
Alcon Inc.: Raising target to $85
Alcon (ALC) Gains From Innovation, Faces FX Challenges
The Next Big Crisis Is Here
You just can’t see it yet because it’s NOT a banking, financial, or economic crisis… it’s far worse and threatens every dollar in your retirement account.
Alcon Prices US$1.3 Billion Senior Notes Offering
Is Now The Time To Put Alcon (VTX:ALC) On Your Watchlist?
2 Surprising Movers in the Stock Market Today
Alcon Reports Third Quarter 2022 Results
Is it a Good Time to Increase Your Alcon (ALC) Position?
See More Headlines
Receive ALC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Alcon and its competitors with MarketBeat's FREE daily newsletter.

ALC Company Calendar

Last Earnings
11/15/2022
Today
1/28/2023
Next Earnings (Estimated)
2/21/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Ophthalmic goods
Sub-Industry
Health Care Facilities
Sector
Medical
CUSIP
04544X30
Employees
24,389
Year Founded
1945

Price Target and Rating

Average Stock Price Forecast
$80.63
High Stock Price Forecast
$92.00
Low Stock Price Forecast
$68.80
Forecasted Upside/Downside
+7.8%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
10 Analysts

Profitability

Net Income
$376 million
Pretax Margin
7.30%

Debt

Sales & Book Value

Annual Sales
$8.29 billion
Cash Flow
$4.65 per share
Book Value
$39.29 per share

Miscellaneous

Free Float
482,638,000
Market Cap
$36.66 billion
Optionable
Not Optionable
Beta
0.85

Social Links


Key Executives

  • Mr. F. Michael Ball (Age 68)
    Exec. Chairman
    Comp: $259.82k
  • Mr. David J. Endicott (Age 58)
    CEO & Director
    Comp: $5.3M
  • Mr. Arthur B. Cummings M.D. (Age 61)
    Exec. Director
    Comp: $197.27k
  • Mr. Timothy C. Stonesifer (Age 56)
    Chief Financial Officer
  • Margaret Buckley
    Chief Accounting Officer
  • Dr. Franck Leveiller
    Sr. VP, Head of Global R&D and Chief Scientific Officer
  • Ms. Sue-Jean Lin (Age 54)
    Sr. VP & Chief Information and Transformation Officer
  • Mr. Royce R. Bedward (Age 57)
    Sr. VP, Gen. Counsel & Corp. Sec.
  • Mr. Laurent Attias (Age 55)
    Head of Corp. Devel., Strategy, BD&L and M&A
  • Ms. Kimberly Martin (Age 48)
    Sr. VP & Chief HR Officer













ALC Stock - Frequently Asked Questions

Should I buy or sell Alcon stock right now?

10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Alcon in the last twelve months. There are currently 1 sell rating, 3 hold ratings and 6 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" ALC shares.
View ALC analyst ratings
or view top-rated stocks.

What is Alcon's stock price forecast for 2023?

10 Wall Street analysts have issued 12 month target prices for Alcon's stock. Their ALC share price forecasts range from $68.80 to $92.00. On average, they expect the company's stock price to reach $80.63 in the next year. This suggests a possible upside of 7.8% from the stock's current price.
View analysts price targets for ALC
or view top-rated stocks among Wall Street analysts.

How have ALC shares performed in 2023?

Alcon's stock was trading at $68.55 at the beginning of the year. Since then, ALC stock has increased by 9.1% and is now trading at $74.80.
View the best growth stocks for 2023 here
.

Are investors shorting Alcon?

Alcon saw a increase in short interest in the month of January. As of January 15th, there was short interest totaling 5,770,000 shares, an increase of 6.7% from the December 31st total of 5,410,000 shares. Based on an average trading volume of 933,700 shares, the short-interest ratio is presently 6.2 days. Currently, 1.2% of the shares of the company are short sold.
View Alcon's Short Interest
.

When is Alcon's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, February 21st 2023.
View our ALC earnings forecast
.

How were Alcon's earnings last quarter?

Alcon Inc. (NYSE:ALC) announced its quarterly earnings data on Tuesday, November, 15th. The healthcare company reported $0.50 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.48 by $0.02. The healthcare company earned $2.12 billion during the quarter, compared to analyst estimates of $2.14 billion. Alcon had a trailing twelve-month return on equity of 6.03% and a net margin of 6.57%.

How often does Alcon pay dividends? What is the dividend yield for Alcon?

Alcon announced a dividend on Saturday, April 23rd. Shareholders of record on Monday, May 2nd will be given a dividend of $0.13 per share on Tuesday, May 3rd. This represents a yield of 0.18%. The ex-dividend date is Friday, April 29th.
Read our dividend analysis for ALC
.

What guidance has Alcon issued on next quarter's earnings?

Alcon issued an update on its FY 2022 earnings guidance on Thursday, December, 15th. The company provided EPS guidance of $2.20-$2.25 for the period, compared to the consensus EPS estimate of $2.28. The company issued revenue guidance of $8.50 billion-$8.70 billion, compared to the consensus revenue estimate of $8.72 billion.

What is Greg D. Wight's approval rating as Alcon's CEO?

6 employees have rated Alcon Chief Executive Officer Greg D. Wight on Glassdoor.com. Greg D. Wight has an approval rating of 100% among the company's employees. This puts Greg D. Wight in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Alcon own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Alcon investors own include AT&T (T), Novartis (NVS), Verizon Communications (VZ), International Business Machines (IBM), Intel (INTC), Pfizer (PFE), Cisco Systems (CSCO), Johnson & Johnson (JNJ), Exxon Mobil (XOM) and AbbVie (ABBV).

What is Alcon's stock symbol?

Alcon trades on the New York Stock Exchange (NYSE) under the ticker symbol "ALC."

Who are Alcon's major shareholders?

Alcon's stock is owned by many different institutional and retail investors. Top institutional investors include AKO Capital LLP (1.15%), Allspring Global Investments Holdings LLC (0.93%), Manning & Napier Group LLC (0.24%), Assenagon Asset Management S.A. (0.11%), Natixis Advisors L.P. (0.10%) and Mcdaniel Terry & Co. (0.05%).

How do I buy shares of Alcon?

Shares of ALC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Alcon's stock price today?

One share of ALC stock can currently be purchased for approximately $74.80.

How much money does Alcon make?

Alcon (NYSE:ALC) has a market capitalization of $36.66 billion and generates $8.29 billion in revenue each year. The healthcare company earns $376 million in net income (profit) each year or $1.15 on an earnings per share basis.

How many employees does Alcon have?

The company employs 24,389 workers across the globe.

Does Alcon have any subsidiaries?
The following companies are subsidiares of Alcon: Alcon (China) Ophthalmic Product Co. Ltd., Alcon Finance Corporation, Alcon Japan Ltd., Alcon Laboratories Inc., Alcon Pharmaceuticals Ltd., Alcon Research LLC, and Alcon Vision LLC.
Read More
How can I contact Alcon?

Alcon's mailing address is Rue Louis-d`Affry 6, Fribourg V8, 1701. The official website for the company is www.alcon.com. The healthcare company can be reached via phone at 41-58-911-2000, via email at investor.relations@alcon.com, or via fax at 41-58-911-3222.

This page (NYSE:ALC) was last updated on 1/28/2023 by MarketBeat.com Staff